Skip to main content
Caplight Logo









Kerna Laboratories

Kerna Laboratories

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://kernalabs.ai/

Last Round

Seed

Jan 13, 2025

Total Funding Raised

$6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Kerna Laboratories Inc. is an AI biotechnology company that develops a platform for creating novel RNA-based medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Foundation

Keywords

mRNA therapeuticsAI drug discoveryfoundation modelsmRNA designgenetic medicinesgenerative biologyprogrammable medicinesAI biotechnologybiotech AIin silico drug discoverymRNA optimizationdrug discovery platformcell-type specific targetingprotein expressionmRNA stability

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kerna Laboratories Comparables

Compare Kerna Laboratories with similar companies based on industry and business-model similarity.

Kerna Laboratories comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Therna Biosciences
90%
Raina Biosciences
88%
Inceptive
86%

Kerna Laboratories Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 13, 2025

Kerna Laboratories Investors

Notable investors and investment history

Kerna Laboratories investors
InvestorRounds
Gradient VenturesSeed
Pioneer FundSeed
StoryHouseSeed
Tau VenturesSeed
Humba VenturesSeed
FocalPoint PartnersSeed
XEIA Venture PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 45% to 1.9K.

  • Nov 7, 2025

    Monthly visitors grew 51% MoM, from 1.3K to 2K.

Kerna Laboratories Filings

Explore SEC and related filing metadata, where available.

Kerna Laboratories filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kerna Laboratories's valuation, stock price, and market status.

Is Kerna Laboratories a public or private company?

Kerna Laboratories is a private company.

What is the current stock price of Kerna Laboratories?

Kerna Laboratories is a private company with no public stock price. No recent secondary market data is available.

How much is Kerna Laboratories worth (valuation)?

Valuation information for Kerna Laboratories is not publicly available.

Can I buy Kerna Laboratories stock?

Kerna Laboratories shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kerna Laboratories's last funding round?

Kerna Laboratories's most recent funding round was Seed on January 13, 2025.

Who are the main investors in Kerna Laboratories?

Key investors in Kerna Laboratories include Gradient Ventures.

Will Kerna Laboratories IPO soon?

No public IPO plans have been announced for Kerna Laboratories.

How can I track Kerna Laboratories secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kerna Laboratories's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range9
Year Founded2024
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?